NCT06089239 is a NA clinical trial of High Intensity Coaching in Accidental Fall, sponsored by University of Florida.

Who is sponsoring NCT06089239?

NCT06089239 is sponsored by University of Florida.

What drugs are being tested in NCT06089239?

Interventions in NCT06089239: High Intensity Coaching, Low Intensity Coaching.

What condition does NCT06089239 study?

NCT06089239 studies Accidental Fall, Patient Safety, Hospital Acquired Condition, Clinical Alarms, Mentoring.

Is NCT06089239 still recruiting?

NCT06089239 is currently recruiting now. Last updated 16 July 2025.

Last reviewed 2025-07-16 · How we verify

NCT06089239

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals

Recruiting now NA Last updated 16 July 2025

What this trial tests

NA trial testing High Intensity Coaching in Accidental Fall in 300 participants. Currently enrolling.

Timeline

1 October 2023

Primary endpoint
2 February 2026

31 August 2026

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	300
Start date	1 October 2023
Primary completion	2 February 2026
Estimated completion	31 August 2026
Sites	24 locations across United States

Drugs / interventions tested

High Intensity Coaching
Low Intensity Coaching

Conditions studied

Accidental Fall — all drugs for Accidental Fall →
Patient Safety — all drugs for Patient Safety →
Hospital Acquired Condition — all drugs for Hospital Acquired Condition →
Clinical Alarms — all drugs for Clinical Alarms →

Sponsor

University of Florida

Who can join

18 and older, any sex, with Accidental Fall or Patient Safety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a Hybrid II de-implementation study to reduce use of fall prevention alarms in hospitals. The intervention consists of tailored, site-specific approaches for three core implementation strategies: education, audit/feedback and opinion leaders. Hospital units will be randomized to low-intensity or high-intensity coaching for the implementation of the tailored strategies.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Alarm with care-a de-implementation strategy to reduce fall prevention alarm use in US hospitals: a study protocol for a hybrid 2 effectiveness-implementation trial.
Turner K, McNett M, Potter C, Cramer E, et al · · 2023 · cited 1× · PMID 38053114 · DOI 10.1186/s13012-023-01325-9
Hospital Fall Prevention Practices and Implementation Strategies: A Multisite Observational Study.
McNett M, Cramer E, Al Taweel M, Potter C, et al · · 2026 · PMID 41937580 · DOI 10.1097/pts.0000000000001500
Selecting and tailoring implementation strategies for deimplementing fall prevention alarms in US hospitals: a group concept mapping study.
Turner K, Al Taweel M, Petrucci C, Rosas S, et al · · 2026 · PMID 40139778 · DOI 10.1136/bmjqs-2024-018391

Verify or expand the search:

Other recruiting trials for Accidental Fall

Currently open trials in the same condition.

NCT07358338 — Application of Device-based Training to Improve Postural Control in Older Adults With CCI · NA · active not recruiting
NCT05822466 — Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults · NA · recruiting
NCT04091464 — TRAIN-BW: Backward Walking Training in Multiple Sclerosis · NA · active not recruiting

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06089239 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 16 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06089239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing